# Aliskiren and Renin Inhibition in Diastolic Heart Failure

> **NCT00773084** · NA · WITHDRAWN · sponsor: **Texas Tech University Health Sciences Center**

## Conditions studied

- Diastolic Heart Failure

## Interventions

- **DRUG:** Aliskiren plus spironolactone vs. Lisinopril plus spironolactone

## Key facts

- **NCT ID:** NCT00773084
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-09
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty in recruiting patients and then the PI left the institution
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773084, "Aliskiren and Renin Inhibition in Diastolic Heart Failure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00773084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*